EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
about
MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasionNoncoding RNAs and pancreatic cancerEmerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Interactions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplayMiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancerCurrent Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsEpigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?microRNA-200b as a Switch for Inducible Adult AngiogenesisPredicting the potential ankylosing spondylitis-related genes utilizing bioinformatics approachesRegulation of miR-200c by nuclear receptors PPARĪ±, LRH-1 and SHPThe expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinomaRegulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.Strengths and limitations of laboratory procedures for microRNA detectionEpigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsPhenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG.MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation.Inverse association between miR-194 expression and tumor invasion in gastric cancer.microRNA-192, -194 and -215 are frequently downregulated in colorectal cancerDiscovery of multi-dimensional modules by integrative analysis of cancer genomic data.dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networksMicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathyClinically relevant microRNAs in ovarian cancerSilencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomasDiscovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer.The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheresmicroRNA signature for human pancreatic cancer invasion and metastasis.Correlation between microRNA-421 expression level and prognosis of gastric cancerChanges in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) modelInferring novel gene-disease associations using Medical Subject Heading Over-representation Profiles.MicroRNA-421 Gene Polymorphism in Gastric Carcinoma.Prognostic significance of miR-194 in endometrial cancer.The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil TreatmentTargeting microRNAs in pancreatic cancer: microplayers in the big game.Pancreatic cancer diagnosis by free and exosomal miRNA.MicroRNAs in pancreatic malignancy: progress and promises.
P2860
Q21562154-CC0F1E8B-3E37-41B1-A90E-462F35131632Q26774630-1068B84B-ABD9-485F-BED3-8FD38E5EDD8FQ26796523-1403C94E-2C85-43DA-BB4C-ED8C418F2351Q26799779-2DC855AA-CBAA-4BA4-A012-3B5DFB7E3064Q26866533-FD027177-6A24-4B17-85FE-DF9ABF7C0599Q27332271-93939E44-4204-4D55-A952-51CDB8B035A5Q28072364-938082AD-1DED-40D9-9C97-E0A99BA24B0DQ28074465-5895EEEF-E814-483B-A178-4323694DFDC4Q28076548-6ADAC2B7-348B-481D-A466-1A61D2C74C9CQ28080485-F252BCDB-797A-469F-A7A8-5065D488F4DEQ28252332-A76F2BD8-B8D9-4F3A-A393-4D6B04613338Q30423418-FE52DD6B-2FCB-4724-8EBF-3B67ACBBB2E8Q33579675-605EAB74-3EDB-44FB-9B30-45F1F6A84B57Q33587316-374D1CC2-66F7-46BC-B0B2-F93F3E05D890Q33715802-0E233F08-EBC9-43BC-8417-BC4AD9681BDDQ33780712-4E808922-4F21-4CA8-A5D6-19E23449575BQ33801377-11A84074-9D36-4F76-8B40-CAFC1949A6D2Q33865456-CB9D693D-8AD9-489A-A7B6-9C348F1CBAB2Q33948651-2FDD049D-5296-43E2-A253-C675FA7414CBQ34003790-3D54E7B2-18C8-4678-AFE6-BB389F97D2D4Q34019957-3FD683B8-F91E-45E3-8A08-53E9929B5230Q34208375-128580C6-6F5F-41D1-99F0-D56074F1EF65Q34299181-12D9B760-12B2-4992-9ADA-01568EFE0290Q34373598-5C3A7999-E7D4-4E5E-AD94-66261A1186D3Q34433952-81EA7EF5-071E-4ED0-8238-4D62AB6CA22DQ34718910-00308A29-0F89-4120-B714-43179556B35AQ35204609-BB929B4B-F919-4691-A0BE-A584EED0E6F7Q35235761-20953560-B761-4E7F-B867-CCC86776ED24Q35760927-FB272639-9931-4428-9F94-A4D845DA4410Q36196598-8801913F-260F-4704-AE2D-64ADF32101A8Q36225874-F67FDB69-8FC5-490C-A598-3B555BD3F651Q36464852-08E489E5-2458-438D-B572-41CCDE3618BBQ36545604-729DC2FF-7BFD-4526-9867-FE726E20777FQ36632948-74F02602-B7B6-4C85-8AD7-46BF1EF1BA0BQ37024984-DA5CEF39-5413-4A1C-88B4-5A5111361B46Q37169644-0EC828A1-1E6B-4972-AF29-E583AFE75166Q37282902-CD7EBF8D-134E-4E21-BB66-1CC11BFF51EEQ37325758-1B9215B5-6D87-4C9F-8B73-022CFF9DCB69Q37382231-A8829993-380F-48EB-A3E1-7732BA2D19B9Q37707057-32550EA9-554B-4F1E-BB57-BDAF914915A6
P2860
EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010幓ć®č«ę
@ja
2010幓å¦ęÆęē«
@wuu
2010幓å¦ęÆęē«
@zh-cn
2010幓å¦ęÆęē«
@zh-hans
2010幓å¦ęÆęē«
@zh-my
2010幓å¦ęÆęē«
@zh-sg
2010幓åøč”ęē«
@yue
2010幓åøč”ęē«
@zh
2010幓åøč”ęē«
@zh-hant
name
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@en
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@nl
type
label
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@en
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@nl
prefLabel
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@en
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@nl
P2093
P2860
P356
P1476
EP300--a miRNA-regulated metas ...... enocarcinomas of the pancreas.
@en
P2093
Christina Schleicher
Claudia Wendel
Edith Willscher
Joerg Haier
Mario Colombo-Benkmann
Nicole Baeumer
Norbert Senninger
Soeren Torge Mees
Wolf Arif Mardin
P2860
P304
P356
10.1002/IJC.24695
P577
2010-01-01T00:00:00Z